Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Lamivudine Stavudine & Nevirapine bulk supplier for pharma manufacturers

Lamivudine Stavudine & Nevirapine Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: Lamivudine 150 mg + Stavudine 30 or 40 mg + Nevirapine 200 mg

Reference Brands: Triomune®(Global)

Category: Anti Viral

Lamivudine, Stavudine & Nevirapine Tablets, often used in first-line HIV treatment, are available in 150/30/200 mg strength. Trusted brands like Triomune® offer affordable and effective ART. Via PharmaB2B, bulk procurement from WHO-GMP suppliers supports government tenders and HIV care programs in developing regions.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Lamivudine, Stavudine & Nevirapine Tablets are a fixed-dose antiretroviral combination widely used in the management of HIV-1 infection, particularly in first-line ART regimens in developing countries. Available in strengths like 150/30/200 mg, this combination ensures improved patient compliance and cost-effective therapy. Marketed under trusted names like Triomune®, the formulation is procured by governments, NGOs, and hospitals across Africa, Asia, and Latin America. Through PharmaB2B platforms, buyers can access high-quality, WHO-GMP-compliant products in bulk for tenders, institutional supply, and public health programs. It remains a vital component in scaling up global HIV treatment access.

Lamivudine Stavudine & Nevirapine — third party manufacturing & bulk supply

Lamivudine Stavudine & Nevirapine is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Lamivudine Stavudine & Nevirapine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Lamivudine Stavudine & Nevirapine →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Lamivudine, stavudine, and nevirapine are used together for the treatment of HIV-1 infection. This triple-drug therapy helps suppress viral replication, increase CD4 cell counts, and slow the progression of HIV. It is commonly used in resource-limited settings as part of combination antiretroviral therapy.

It is made from three active substances: Lamivudine, a nucleoside reverse transcriptase inhibitor (NRTI); Stavudine, another NRTI; and Nevirapine, a non-nucleoside reverse transcriptase inhibitor (NNRTI). Together, they block HIV replication at different stages.

Common trade names include

Triomune was originally manufactured by

The generic name is Lamivudine + Stavudine + Nevirapine.

The most recognized brand name is

It is manufactured in India by multiple approved pharmaceutical manufacturers, including Cipla and other licensed generic producers.

Related Products

Cobicistat

Strength:
150 mg

Form: Tablets

Reference Brands: Tybost (USA/EU)

View Details
Brincidofovir

Strength:
100 mg, 10 mg/ml

Form: Tablets / Oral suspension

Reference Brands: Tembexa (USA/EU)

View Details
Lenacapavir

Strength:
300 mg, 463.5 mg/1.5 mL

Form: Tablet / Injection

Reference Brands: Yeztugo (USA), Sunlenca (USA)

View Details
Fostemsavir

Strength:
600 mg

Form: Tablets

Reference Brands: Rukobia (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.